Reduced PTEN and PPP2R2B expression correlated with activated AKT/mTOR and PDK1/MYC pathways, which can confer considerable BEZ235 resistance in nasopharyngeal carcinoma. The gene discussed is PPP2R2B; the disease is nasopharyngeal carcinoma.